Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Retinoic acid°¡ ¹é¼­ÀÇ ÇÇÇÏ¿¡ ÁÖÀÔµÈ ½Å°æ¾Æ¼¼Æ÷Á¾(neuroblastoma)ÀÇ ¼ºÀå ¹× ¹é¼­ÀÇ »ýÁ¸¿¡ ¹ÌÄ¡´Â ¿µÇâ Effect of Retinoic Acid on the Growth of Subcutaneously Injected C1300 Neuroblastoma and on the Survival of the Host A/J Mice

´ëÇѾÏÇÐȸÁö 1994³â 26±Ç 1È£ p.113 ~ 118
¹ÚÈñºØ, Á¶º´ÁØ, Àå¹Ì¼÷,
¼Ò¼Ó »ó¼¼Á¤º¸
¹ÚÈñºØ (  ) 
¿¬¼¼´ëÇб³

Á¶º´ÁØ (  ) 
¿¬¼¼´ëÇб³
Àå¹Ì¼÷ (  ) 
¿¬¼¼´ëÇб³

Abstract


Deficiency of vitamin A and/or its precursors has been associated with increased cancer risk in animals and humans. Therapeutic trials of vitamin A and related compounds(retinoids) have demonstrated activities in several cancerous and
precancerous
conditions. We measured the effects of a retinoic acid on the growth of subcutaneously injected C1300 neuroblastoma and on the survival of the host A/J mice. The fifty A/J mice were inoculated with 106 of C1300 neuroblastoma cell in the right
back.
They
were divided into five groups. One group received saline as a control. Two groups recieved 2mg/kg and 5mg/kg of retinoic acid . The other two groups recieved low dose(50mg/kg and 100mg/kg) cysclophosphamide. Tumor volume and survival were
assessed.
The
survivals were significantly increased(p<0.05) in three groups, mice recieved 5mg/kg of retinoic acid, 50mg/kg and 100mg/kg of cyclophosphamide. Tumor volumes of the mice treated with 5mg/kg of retinoic acid were significantly lower than the
control
group(p<0.05). Retinoic acid suppressed the growth of neuroblastoma, it increased the survival of the treated mice if adequate doses were used.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸

KoreaMed
KAMS